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A magnetic graphene quantum dot (MGQD) nanoparticle, synthesized by 
hydrothermally reducing and cutting graphene oxide-iron oxide sheet, was 
demonstrated to possess the capabilities of simultaneous confocal fluorescence and 
magnetomotive OCT imaging. This MGQD shows low toxicity, significant tunable 
blue fluorescence and superparamagnetism, which can thus be used as a dual-
modality contrast agent for confocal fluorescence microscopy (CFM) and 
magnetomotive OCT (MMOCT). The feasibility of applying MGQD as a tracer of 
cells is shown by imaging and visualizing MGQD labelled cells using CFM and our 
in-house MMOCT. Since MMOCT and CFM can offer anatomical structure and 
intracellular details respectively, the MGQD for cell tracking could provide a more 
comprehensive diagnosis. 
  
 
 
1 INTRODUCTION 
 
Cell therapy, which utilizes human or animal cells as therapeutic entities, has been 
regarded as a new revolution in medicine [1, 2]. It is being rapidly developed to treat 
diseases such as traumatic brain injury [3], ischaemic heart disease [4], stroke [5], 
diabetes [6] and limbal epithelial stem cell deficiency (LESCD) [7]. A major 
challenge for cell therapy is evaluation or comparison of therapy outcomes to 
determine the best cell type, route, site of transfer, dose, frequency etc. A variety of 
non-invasive imaging techniques for tracking transplanted cells in vivo have been 
developed to address the challenge. The main imaging technologies developed for 
tracking cells are radionuclide, X-ray computed tomography (CT), magnetic 
resonance imaging (MRI) and optical imaging [8-11]. 
 
Each imaging technique has own advantages and limitations. Radionuclide imaging 
techniques, such as single photon emission computed tomography (SPECT) and 
positron emission tomography (PET), visualize cells labelled with radioactive 
isotopes. These have excellent sensitivity, but their application has been limited by the 
radiation damage, short half-life of tracer and lack of anatomical information [12, 13]. 
CT can obtain anatomical images with spatial resolution of around ȝPusing heavy 
element materials, such as gold and bismuth, for cell tracking; hence concerns over 
  
the toxicity of the contrast agent have been raised [14, 15]. Another limitation of CT 
is that X-ray exposure may result in a risk of cancer and other damage tissue [16]. 
MRI possesses good spatial resolution (10-100 ȝP) [14]. The most common tracer for 
MRI is superparamagnetic iron oxide (SPIO) nanoparticles, which has been clinically 
approved because of the good biocompatibility [17, 18]. The main disadvantages of 
MRI are low sensitivity and long acquisition time [13]. High concentrations of 
magnetic nanoparticles in cells are required for tagging cells due to the low sensitivity 
[19]. 
 
Compared with other image techniques, optical imaging microscopies, such as wide-
field microscopy, confocal microscopy (CM), multi-photon laser scanning 
microscopy and optical coherence tomography (OCT) have a lot of advantages, 
including cellular level resolution, high sensitivity, strong molecular specificity and 
non-ionizing radiation [20, 21]. These optical imaging microscopies have been widely 
applied for molecular and cell biology, due to the excellent resolution [20]. However, 
optical imaging has limited signal penetration depth due to scattering and absorption 
of light in tissue. For example, confocal microscopy and multiphoton microscopy 
provide LPDJLQJGHSWKRIȝP and 500ȝP respectively [22], while  
OCT can image to 1-2 mm depth, albeit with worse resolution (10ȝP) [22]. As OCT 
can provide considerable imaging depth and good enough resolution to easily 
differentiate tissue structure, it has been clinically used for providing anatomical 
morphology of tissue in ophthalmology, cardiology and urology [22, 23]. In addition, 
OCT has features for low cost, portable system, high acquisition rate and easy 
integration into catheters, hand-held probes or needles; these features let OCT be ideal 
  
for intraoperative imaging [22]. Limitations of OCT include a lack of sub-cellular 
resolution and insensitivity to fluorescence emission. 
 
Therefore, a contrast agent which could be utilized for diverse imaging modalities 
would offer more comprehensive information. In this paper, a contrast agent for 
combined OCT and CM will be described, as it has the potential to provide both 
anatomical information and valuable intracellular details. 
 
OCT is an optical analog of ultrasound imaging, in which the depth-resolved 
backscatter from a sample is measured from photon time-of-flight information, 
recorded indirectly using low-coherence interferometry [24]. The technique was 
originally implemented in the time-domain, but modern systems almost exclusively 
use Fourier-domain processing. Fourier-domain OCT (FD-OCT) does not require a 
mechanically scanned reference arm, allowing higher A-scan rates than TD-OCT. It 
has been shown that FD-OCT has a >100-fold increase in sensitivity compared with 
TD-OCT [25]. 
 
Similar to CM, the lateral resolution of OCT is limited by the NA of objective, which 
is defined as ο ൌ ͲǤ͸ͳɉȀ, where ɉ is the wavelength of light [26]. However, the 
axial resolution of OCT is determined by the coherence length of the light source. The 
light source with lower coherence length will produce better axial resolution, 
expressed as ο ൌ ୡ ʹΤ ؆ ͲǤͶͶɉଶ ȟɉΤ , where ȟɉ is bandwidth of light and ୡ is the 
coherence length of light [26]. Because the axial resolution of OCT can be improved 
by using lower coherence laser source, instead of increase of NA, OCT commonly 
uses low NA objective for long work distance, deeper imaging depth and a large 
  
FOV. In OCT, specimen is usually illuminated using near-infrared light, because most 
tissues have a good transparency at near-infrared wavelengths [24, 27]. 
 
Since the invention of OCT, various materials have been studied as potential contrast 
agent. The most common contrast agent is gold nanoparticles with various shapes, 
involving nanospheres, nanoshells, nanorods, nanocages etc., which is attributed to its 
surface plasmon resonance effect causing strong size-dependent absorption or 
scattering at near-infrared wavelengths [24, 28]. Since the development of 
Spectroscopic OCT, dyes which have a strong absorption or scattering peak in the 
OCT spectral window also become an important contrast agent, such as indocyanine 
green and fluorescent microspheres [29, 30]. An approach of locating magnetic 
particles within tissue using magnetomotive OCT (MMOCT) has been investigated 
for tracking magnetically labelled cells [31]. In this case, superparamagnetic iron 
oxide (SPIO) has become the most prevalent contrast agent because of its high 
magnetic susceptibility, good biocompatibility and easy preparation. It has been 
reported that ultralow concentrations of SPIO (27 µg/g) within tissue can be detected 
by MMOCT [32]. The combination of SPIO and MMOCT has been used to track 
macrophage and platelet, and diagnose breast cancer, atherosclerosis and thrombosis 
[24, 33-35]. 
 
Cell tracking by fluorescence microscopy relies on fluorescence tags to label and 
locate cells. Most fluorescence probes are either organic fluorophores or quantum dots 
(QDs). Research work on the quantum dot has been pursued, because organic 
fluorophores suffer photobleaching and broad overlapping emission lines [10]. QDs 
are nano-scale nanocrystals, which shows robust fluorescence due to quantum 
  
confinement effect. QDs have many advantages over organic fluorophores, including 
size-tunable light emission, broad excitation spectra with narrow emission spectra and 
20 times brighter and 100 times more stable fluorescence [36, 37]. In earlier research, 
QDs composed of II±VI (e.g., CdSe, CdS, CdTe) or III±V (e.g., InP, InAs) alloys 
were developed for their excellent fluorescence [38-40]. However, the applications of 
these QDs in medicine have been limited by the potential  toxicity from heavy metals 
[41]. QDs based on carbon (e.g., carbon nanotubes, graphene) and silicon (e.g., 
porous silicon nanoparticles) have been investigated to avoid usage of heavy metal; 
the results demonstrate that carbon or silicon based QDs have high biocompatibility 
and efficient fluorescence, thereby, facilitating biomedical applications [41, 42]. 
 
The benefits of QDs and SPIO for contrast agents have inspired us to investigate a 
hybrid QDs and SPIO combination for confocal fluorescence microscopy (CFM) and 
MMOCT. A recent study shows that a hybrid of graphene and iron oxides, called 
magnetic graphene quantum dots (MGQD), displays both fluorescence and 
superparamagnetism [43]. Its properties allow one to integrate CFM and MMOCT in 
application of cell tracking, thereby possibly simultaneously offering anatomic 
structure and intercellular details for tissue. In this study, the feasibility of using 
synthesized MQGD as a contrast agent for MMOCT and CFM will be evaluated. 
 
2 MATERIALS AND METHODS 
 
2.1 Synthesis of MGQD 
 
  
MGQD nanoparticles were synthesized following a previously reported method [43], 
with some modifications. First, graphene oxide was prepared from graphite by a 
modified Hummers method [44]. 0.2 g of graphene oxide was then added into 30 mL 
of distilled water, dispersed by sonication (60Hz) for 1 hour. The pH value of the 
suspension was adjusted to 10 by addition of ammonium hydroxide (NH4OH). 0.8 g 
of ferric chloride hexahydrate (FeCl3-6H2O, 97%) and 1.04 g of ferrous chloride 
tetrahydrate (FeCl2-4H2O, >99%) were dissolved into 27 mL distilled water. The 
ferric salt solution and graphene oxide suspension were mixed up, and NH4OH was 
added dropwise until the pH value reached 10. The mixture was stirred for 2 hours 
under nitrogen atmosphere, forming graphene oxide-iron oxide. The precipitate was 
then centrifuged and washed several times by water and ethanol until the supernatant 
became clear, to eliminate uncoated graphene oxide and ions. The graphene oxide-
iron oxide was dispersed in 500 mL distilled water and autoclaved by a Parr Series 
4000 autoclave at 200 ႏ for 10 hours, forming shattered reduced graphene oxide-iron 
oxide nanoparticles, namely MGQD. Then, residual chemicals in the MGQD 
suspension were removed by dialysis using Fisher Scientific Biodesign Dialysis 
tubing (molecular weight cut off = 3.5kDa). Finally, the MGQD was dried by freeze 
drying for storage. All chemicals used above were purchased from Sigma-Aldrich. 
 
2.2 Characterization of MGQD 
 
Transmission electron microscopy (TEM) image of MGQD was achieved using FEI 
tecnai Biotwin 120 kV machine, operating at accelerating voltage of 80 kV. The 
electron was emitted by a tungsten filament, and images were recorded on a Gatan 
Orius SC1000B bottom mounted camera with Gatan Digital Micrograph Software. 
  
7(0VDPSOHZDVSUHSDUHGE\HYDSRUDWLQJȝ/GLOXWHGVXVSHQVLRQDERXW
0.01mg/mL) on a carbon film on 200 mesh copper grids. Magnetic hysteresis loop of 
MGQD was measured by Quantum Design MPMS-XL 5 superconducting quantum 
interference device (SQUID). 0.016 g of MGQD powder was placed in SQUID, 
operating with a magnetic field between +20,000Oe and -2HDWႏMagnetic 
hysteresis loop of SPIO was measured as a control. Fluorescence spectra of MGQD 
were detected using PerkinElmer LS 55 fluorescence spectrometer. The samples of 
fluorescence spectrometer were prepared by diluting suspension to about 0.02 mg/mL. 
 
2.3 Cell Culture and Labelling 
 
Cell culture media were prepared by mixing 219mL DMEM+Glutamax (Sigma, 
'P/+DP¶V)6LJPD1P/IHWDOFDOIVHUXP6LJPD)
5mL Penicillin (Sigma, P0781), 5mL Fungizone (Sigma, A2942), 2.5mL insulin 
(Sigma, 91077C) and 0.025ml EGF (Sigma, E5036). 3T3 cells (derivation of the 3T3 
mouse fibroblast cell line) were cultured by adding î cells and the 10 mL of 
medium into a T75 cell culture flask and putting the cell culture flask into incubator 
until the cells attach and spread out on the bottom. During this time, the medium was 
renewed once every two days. 
 
A series of concentration (0-ȝJP/RI0*4'PHGLDZHUHSUHSDUHGE\
ultrasonically dispersing dried MGQD into media. After cell culture was completed, 
MGQD media were used to replace the original cell media for cell labelling. These 
cells and MGQD media were put into an incubator for one day. Then, the labelled 
cells were washed with PBS 5 times. 2.5 mL of trypsin-EDTA was dropped into flask 
  
to make the cells detach flask. The solution of trypsin-EDTA and cells was added into 
7.5 mL medium. The cells in the solution were separated by spinning at 1000 RPM 
for 5mins. 2 mL medium was added to the separated cells, and the number of cells 
was calculated by a hemocytometer. 
 
2.4 Toxicity Test by MTT 
 
3T3 cells were seeded into 96-well plates containing 200 µl of RPMI medium (Lonza, 
BE12-918F) supplemented with 10 % Foetal Bovine Serum (Thermo Fisher, 
10500064), 1 % Penicillin-Streptomycin (Lonza, DE17-603E) and 1 % L-Glutamine 
(Lonza, 17-605F)). The cell seeding density was 5 × 103 cells per well and the cells 
were incubated overnight at 37 °C under 5% CO2 atmosphere. Then, the cells were 
washed twice using PBS buffer and incubated with ȝORIPHGLXPZLWKYDULRXV
FRQFHQWUDWLRQVRI0*4'$IWHUKRXUVDQGKRXUVȝORIPJPO077
reagent was added into each well and the cells were incubated for another 3 hours. 
The supernatants were removed and 200 µL of DMSO was added into each well. The 
absorbance of each well was measured by a plate reader (FLUOstar galaxy, BMG 
LABTECH, Germany) using 570 nm wavelength. 
 
2.5 CFM Imaging 
 
Confocal imaging of MGQD powder and MGQD labelled cells was performed with 
an inverted Zeiss LSM 510 NLO microscope. The microscope is equipped with a 30 
mW Ar laser (458, 477, 488, 514 nm), a 1.2 mW 543 nm He/Ne laser, a 5 mW 633 
nm HeNe laser and a Coherent Chameleon femto-second pulsed laser (690-1040 nm) 
  
suitable for multiphoton imaging. The MGQD was imaged by two-photon excitation 
using the Coherent Chameleon femto-second pulsed laser. A META multi-
wavelength detector was used to collect emitted light from a particular band. 
 
A small quantity of MGQD powder was placed on a microscope slide for CFM 
imaging. The MGQD labelled cells have been imaged twice. For the first 
measurement, MGQD labelled cells were fixed on a glass bottomed dish (Thermo 
Fisher, 150680) using 3.7% paraformaldehyde (in PBS), and visualized directly using 
690 nm exciting light. For the second measurement, the MGQD labelled cells were 
also fixed on a glass bottomed dish, and the F-actin and nucleus of cells were stained 
by diluted phalloidin-FITC (0.2 µg/mL) and DAPI (1 µg/mL) respectively for 
highlighting cell shape. The stained cells were imaged using 4 nW laser power at 488 
nm and 0.989 mW laser power at 700 nm. The 488 nm laser was used to excite 
fluorescence of phalloidin-FITC and images F-actin through a 500-550 nm filter. The 
two-photon fluorescence of DAPI and MGQD was excited by the 700 nm laser and 
imaged through a 435-485 nm and a 362-415 nm filter, respectively. A control 
experiment was conducted by imaging unlabeled cells in the same way. The laser 
powers used for fluorescence excitation were measured by an optical power meter 
(PM 400, Thorlabs). 
 
2.6 Construction of MMOCT 
 
An in-house MMOCT system was constructed based on a custom-built ultrahigh 
resolution spectral domain OCT system, shown in Figure 1. A dual super luminescent 
diode source (Broadlighter D890-HP, Superlum) with 890 nm center wavelength and 
  
150 nm bandwidth was used as the light source. The source bean was split into 
reference and sample beams by a 50/50 coupler. The sample beam was deflected by a 
pair of galvanometer scanners (TSH 
22556-Y and TSH 22555-X) and focused on a sample by a focus lens (Thorlabs, 
LSM02-%%ZLWKHIIHFWLYHIRFDOOHQJWKRIPPDQGVSRWVL]HRIȝP7KH
galvanometer scanners allow the sample beam to achieve a volumetric scan of a 
sample. The reference beam was reflected by a plane mirror in reference arm. A 
variable neutral density filter was placed into the reference arm for attenuating the 
reference beam. The sample and reference beams were recombined at the 50/50 
coupler and propagate to an in-house spectrometer. As the optical path difference 
between the reference and sample beams is less than coherence length of light source, 
the interference of reference and sample beams was detected by the spectrometer. An 
A-scan was obtained by Fast Fourier Transform of the interference pattern, and 500 
A-scans were used to construct a B-scan forming an image of width 2 mm. The A-
scan acquisition rate was 1000 Hz. The axial and lateral resolutions of this system 
UHDFKHGȝPDQGȝPUHVSHFWLYHO\DQGWKHVHQVLWLYLW\ZDVG% 
 
A homemade electromagnet, an amplifier (7224 DC-Enabled AC Amplifier, AE 
TECHRON) and a function generator (TENMA 72-6805) were introduced to the OCT 
system to generate sinusoidal magnetic field. Sample was exposed to the magnetic 
field when image was acquired. 
 
  
 
FIGURE 1. The schematic of custom-built MMOCT system, where PC is polarization 
controller, CL is calibrating collimator, FL is focus lens DC is dispersion compensator and 
NDF is neutral density filter. A dual super luminescent diode source (Broadlighter D890-HP, 
Superlum) emitting 890nm of light with a bandwidth of 150 nm was used. The emitted beam 
passed through an optical fiber isolator (IO-F-SLD150-895, Thorlabs), and then was split into 
sample arm and reference arm by 50/50 coupler (Nufern 630-HP fiber, Gould Fiber Optics). 
The sample beam passed through a polarization controller ( PolaRITETM, General Photonics) 
and a collimator ( PAF-X-5-B, ThorLabs) before being deflected by galvo-mounted mirrors, 
and focused by a telecentric OCT scan lens (LSM02-BB, Thorlabs). The reference beam 
passed through a collimator (PAF-X-5-B, ThorLabs) and a dispersion compensator 
(LSM02DC, Thorlabs) before being reflected by a fixed plane mirror, and its intensity was 
adjusted by an adjustable neutral density filter. The spectrometer in this system for detecting 
recombined sample and reference beams was made up of a 1200-line pair per mm diffraction 
grating (Wasatch Photonics, Inc.) and 2048 pixel line scan camera (Aviiva, 
EV71yEM1GE2014-BA9, e2v). A homemade electromagnet, a functional generator 
(TENMA 72-6805) and an amplifier (7224 DC-Enabled AC Amplifier, AE TECHRON) were 
introduced to generate a sinusoidal magnetic field at 80Hz for inducing magnetomotive signal 
of sample. 
 
2.7 MMOCT imaging 
 
Since agar gel has shown similar mechanical properties to soft tissue [45], agar was 
used to mimic human soft tissue in this experiment. The agar gel was prepared by 
shaking and microwave heating of 10 g/L agar solution. As one of our clinical 
application areas is tracking transplanted corneal stem cells [46], MGQD labelled 
cells were deposited on the surface of agar gel for acquisition of MMOCT image. 
 
  
The MMOCT samples were placed over electromagnet, 1 cm away from the top of 
the electromagnet, in an 80-Hz sinusoidal magnetic field with strength of 0.05 T. The 
scanning scheme for MMOCT imaging was implemented by a successively scanning 
along the transverse dimension with a high degree of spatial oversampling and 
temporal oversampling, which must satisfy the following condition: 
 ௭݂ ൐ ʹ ஻݂ ൐ ଶ௩ο௫                                                                                                                                (1) 
where ௭݂  is the axial line acquisition rate, ஻݂  is the magnet modulation frequency, οݔ 
is transverse resolution and ݒ is transverse scan velocity [32]. In the experiment, an 
axial acquisition rate of 1 kHz and 5000 A-scans for 2 mm scan distance were 
applied, resulting in the transverse scan velocity ݒ of 0.4 mm/s. 80 Hz magnetic 
modulation frequency were chosen to meet the condition (1). The phase of each A-
scan was unwrapped and spatially localized frequency spectrum of the phase change 
was computed by a Short Time Fourier Transform (STFT). The magnetomotive signal 
of paramagnetic nanoparticles appears at twice the field modulation frequency i.e. 160 
Hz (or its harmonics) and was thus extracted by a band-pass filter centered on 160 Hz 
(or harmonic). The STFT window length was 50 points, corresponding to a lateral 
UHVROXWLRQRIȝP 
  
3. RESULTS AND DISCUSSION 
 
3.1 MGQD Structure 
 
The morphology of synthesized MGQD has been investigated by TEM, shown in 
Figure 2. The MQGD is approximately a round thin sheet with around 15 nm of 
average diameter. The diameter of this MGQD is smaller than that of the MGQD 
  
reported by Justin et al [43], presumably because of the different graphene oxide 
powders and conditions used for synthesizing the MGQDs. Compared with other 
popular nanoparticles for cell labelling, e.g. standard SPIO (with a diameter of 50-150 
nm) [47] and commercial gold nanoparticles (with a diameter of 30-90 nm)[48], the 
size of MGQD is relatively small. The small size could benefit MGQD uptake, since 
nanoparticles with small size could require less surface energy creation during the 
cellar internalization process [49]. In Figure 2, it is expected that the light gray areas 
are uncovered graphene, while the dark gray regions result from iron oxide coated 
graphene. Hence the TEM suggests that the distributions of size, shape and coating 
area of iron oxides is uneven. 
 
 
FIGURE 2. TEM images of MGQDs with magnification of 30000 (left) and 98000 (right), 
where the light black and dark black areas could be uncovered graphene and iron oxides 
coated graphene respectively. 
 
3.2 Magnetism of MGQD 
 
The iron oxides on graphene were synthesized from co-precipitation of ferrous and 
ferric ions under alkaline condition, which can be exemplified by Fe2+ + 2Fe3++ 
8OH-ĺ)H3O4 (magnetite) +4H2O [43]. This results in graphene oxide particles coated 
with magnetite. A hydrothermal reaction is then used to cut these particles, yielding 
  
nanometre-scale MGQD. The hydrothermal cutting also oxidize a fraction of the 
magnetite, transforming it into PDJKHPLWHȖFe2O3) [50]. Therefore, the iron oxides 
containing a mixture of magnetite and maghemite were produced on the graphene 
surface [43]. The iron oxides can provide strong superparamagnetism for MMOCT 
imaging. To quantify the magnetic properties, the magnetic hysteresis curve of 
MGQD was measured using a SQUID magnetometer, and commercial SPIO 
nanoparticles (Sigma-Aldrich) which have been widely used as an MMOCT contrast 
agent was also measured for comparison. Both results are shown in Figure 3a. The 
saturation magnetization of MGQD is 41.7emu/g, higher than the MGQD reported 
previously (7.31 emu/g) [43]. We have observed that preventing oxidation of Fe2+ by 
atmospheric oxygen both during the preparation of the ferrous iron solution and 
during the co-precipitation of magnetite can increase the saturation magnetization of 
MGQD significantly. We perform both of these steps under a 100% nitrogen 
atmosphere, which thus could explain our higher saturation magnetization. The 
absence of coercivity revealed in the magnetic hysteresis curves of MGQD and SPIO 
shows that both MGQD and SPIO are superparamagnetic, and hence suitable for 
tracer agents in MMOCT. 
 
As the magnetomotive contrast in MMOCT is generated by an oscillation of magnetic 
nanoparticles in an alternating magnetic field, a relatively high magnetic susceptibility 
of nanoparticle is required for inducing sufficient translational force. The translational 
force (F) can be defined as: ܨԦ ൌ ௏ሺI?I?ିI?I?ሻ׏ȁ஻ሬԦȁI?ଶI?I?                                                                                                                  (2)  
where ܸ is the particle volume, ߯௠ and ߯଴ are the magnetic susceptibilities of the 
particle and the tissue respectively, ܤ is magnetic flux density and ߤ଴ is the 
  
permeability of free space[31]. The (bulk) magnetic susceptibilities (߯) and 
magnetization (M) are related by the following relationship: ܯ ൌ ߯ܪ                                                                                                                     (3) 
where H is the magnetic field strength. The the magnetic susceptibilities of MGQD 
and SPIO have been plotted in Figure 3b. As expected, MGQD has lower 
magnetization and magnetic susceptibility than SPIO, since the mass ratio of iron 
oxides in MGQD is less thDQ63,2¶V7KHPDJQHWLFVXVFHSWLELOLW\RI0*4'VDUH
FRPSDUDEOHWR63,2¶V in magnetic field of 100-10000 Oe, and is much higher than 
human tissue (ȁɖȁ̱ͳͲିହ) [31]. Hence, MGQD could offer reliable performance as a 
contrast agent for MMOCT. 
 
FIGURE 3. a: the magnetic hysteresis curves of MGQD and SPIO; the MGQD and SPIO 
have 41.7emu/g and 75.2emu/g of saturation magnetization respectively. b: the magnetic 
susceptibilities of MGQD and SPIO in magnetic field of 100-10000 Oe; magnetic 
susceptibilities of MGQD and SPIO decrease with increasing magnetic field strength; at the 
lowest field strength (100 Oe), the magnetic susceptibilities of MGQD and SPIO are 0.112 
and 0.182 respectively; the magnetic susceptibilities of MGQD and SPIO are 0.027 and 0.050 
respectively at the highest field strength (1200 Oe). 
 
3.3 Fluorescence of MGQD 
 
Pan et al (2010) have synthesized a carbon-based material, graphene quantum dot 
(GQD), which has a strong ߨ ՜ ߨכ absorption peak at 320 nm and a blue 
photoluminescence or fluorescence at 430 nm [51]. The GQD was formed by 
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K\GURWKHUPDOUHGXFWLRQRIJUDSKHQHR[LGHDWႏ,WLVH[SHFWHGWKDW0*4'KDVWKH
similar blue fluorescence because MGQD was synthesized by reducing and cleaving 
iron oxide-graphene oxide sheets in the same way. The fluorescence of MGQD has 
been investigated by a fluorescence spectrometer to initially assess whether the 
synthesized MGQD can be used as tracer in fluorescence microscope, shown in 
Figure 4. As with GQD [51], an absorption peak at 320 nm is also be observed for the 
MGQD. However, the excitation peak becomes 360 nm rather than 430 nm due to 
effect of the coated iron oxides and change of particle size. Our 360 nm excitation 
peak is also different from the MGQD synthesized previously (excitation peak 398 
nm) [43]. This might be because of the smaller size of our MGQD, which is expected 
to yield a larger band gap due to enhanced quantum confinement of the electrons [52]. 
The peak emission intensity of MGQD can be tuned by tuning the excitation 
wavelength, shown in Figure 4b, which is the same as GQD synthesized by Pan et al 
[51]. Visible fluorescence with a peak at 415 nm was excited using 360 nm excitation. 
Therefore, the MGQDs have the potential to be contrast agent for CFM. 
 
FIGURE 4. Fluorescence spectra of MGQDs. a: The excitation wavelength versus emission 
ZDYHOHQJWKZKHUHWKHHPLVVLRQVSHFWUXPH[FLWHGE\QPRIOLJKWLVVKRZQDV³(PLVVLRQ
VSHFWUXP´DQGWKHH[FLWDWLRQVSHFWUXPRI0*4'PHDVXUHGE\DIL[HGZDYHOHQJWKDW
360 QPLVVKRZQDV³([FLWDWLRQVSHFWUXP´b: The emission spectrums of MGQDs 
excited by 320 nm, 330 nm and 360 nm respectively, showing excitation-dependent 
fluorescence behaviors of MGQDs. 
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3.4 Toxicity of MGQD 
 
It is essential that nanoparticles for cell labelling have very low toxicity for cells. 
Hence, the effect of MGQD on 3T3 cell line has been tested by MTT method, shown 
in Figure 5. The 3T3 cells in the media containing 0-ȝJP/MGQDs retain more 
than 87FHOOYLDELOLW\DWDQGKRXUV¶LQFXEDWLRQWLPHV In contrast, SPIO 
QDQRSDUWLFOHVȝJP/ZKLFKKDYHEHHQZLGHO\DSSOLHGDVDFRQWUDVWDJHQWIRU
MRI show a cell viability of 80% after 24 hours culture [53]. Therefore, MGQDs in 
concentration below ȝJP/GLVSOD\H[WUHPHO\ORZF\WRWR[LFHIIHFWVWR7FHOOV
For MMOCT and CFM imaging, the 3T3 cells were labelled by 24-hour culturing in 
PHGLXPFRQWDLQLQJ0*4'LQWKHFRQFHQWUDWLRQEHORZȝJP/VR0*4'LV
considered as a safe contrast agent for MMOCT and CFM. 
 
FIGURE 5. 7KHLQIOXHQFHRI0*4'LQFRQFHQWUDWLRQVRIDQGȝJP/RQ
cell line viability of 3T3 cell line after 24 and 48 hours culture. 
 
3.5 CFM imaging of MGQD 
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It has been shown that MGQD exhibits tunable fluorescent behavior within the 
exciting wavelength range of 320-360nm. Hence, two-photon fluorescence of MGQD 
should be excitable by a laser with wavelength around 700 nm. The fluorescence of 
MGQD powder has been imaged by CFM using 740 nm excitation light, shown in 
Figure 6a. A blue fluorescence signal was detected in the wavelength range 435-485 
QP7KH7FHOOVODEHOOHGE\LQFXEDWLRQLQȝJP/0*4'PHGLXPIRUKRXUV
have been visualized through CFM using 690 nm excitation light, shown in Figure 6b. 
The MGQD is internalized into cells and can be recognized by its fluorescence signal 
in the CFM image. However, some aggregation of MGQD occurs and thereby inhibit 
a portion of fluorescence. The aggregation effect could be a limitation of MGQD for 
CFM application, as MGQD tends to aggregate at high concentration, possibly due to 
the presence of weak remnant magnetization. It should also be noted that these 
0*4'¶VKDYHQRWEHHQVWHULFVWDELOL]HGHJE\3(*\ODWLRn. In Figure 6c, the 3T3 
FHOOVODEHOOHGE\ȝJP/0*4'PHGLXPDUHLPDJHGXVLQJQPH[FLWLQJOLJKW
where the cell nucleus (in red) and actin (in green) were stained by DAPI and 
phalloidin-FITC respectively. The fluorescence signal of MGQD is observed within 
the cell nucleus and also attached to actin filaments in the range of 362-415 nm 
wavelength and highlighted in blue in Figure 6c. There is no specific region where 
MGQD tends to aggregate. Figure 6d is the CFM image of unlabeled cells for 
negative control, in which blue fluorescence signal is not evident. 
 
  
 
FIGURE 6. The CFM images of MGQD powder and MGQD labelled cells, where MGQD, 
cell nucleus and actin are shown in blue, red and green respectively. a: MGQD powder (×40 
magnification, 1.2 NA) imaged using 3.75 mW 740 nm excitation light and 390-465 nm 
emission filter; bȝJP/0*4'ODEHOOHG7FHOOVî20 magnification, 0.8 NA) imaged 
using 14.35 mW 690 nm excitation light and 543 nm transmission light, where the 
fluorescence of MGQD is obtained by 362-415 nm filter; cȝJP/0*4'ODEHOOHG7
cells (×40 magnification, 1.2 NA) imaged using 0.989 mW 700 nm and 4 nW 488 nm 
excitation lights, where the MGQD and DAPI are excited with 700 nm light, phalloidin-FITC 
is excited with 488 nm light and 362-415 nm, 435-485 nm and 500-550 nm filters are used to 
obtain the fluorescence of MGQD, DAPI of cell nucleus and phalloidin-FITC of actin, 
respectively; d: unlabeled 3T3 cells (×20 magnification, 0.8 NA) imaged using the same 
excitation lights and emission filters as c for comparison. 
 
3.6 MMOCT imaging of MGQD 
 
MGQD labelled 3T3 cells are loaded on surface of agar gel for MMOCT imaging, 
where the agar gel is utilized to mimic human soft tissue. An 80 Hz sinusoidal 
magnetic field generated by an electromagnet is applied for exerting force on MGQD 
and generating magnetomotive signal of MGQD. The translative force vector of 
  
MGQD (ܨԦ) is parallel with the magnetic field vector (ܤሬԦ) and the axial direction of A 
scan (z), which can be expressed as: ܨԦ ൌ ܸሺܯ௥ ൅ I?I?I?I?ܤ௭ሻ I?஻ሬԦI?௭                                                                                              (4) 
where ܯ௥ is remnant magnetization. The remnant magnetization is negligible due to 
the superparamagnetism of MGQD. The magnetomotive force is unidirectional 
because of the positivity of ߯௠ and ܤ௭ I?஻ሬԦI?௭. Therefore, the oscillation of MGQD should 
have double the frequency of the magnetic field modulation. The frequency spectrum 
RIȝJP/0*4'ODEHOOHGFHOOVRQDgar (densityൎ  ൈ cell/cm2) has been 
detected by MMOCT, shown in Figure 7b. A 320 Hz of magnetomotive signal 
(intensityൎ  ൈ  a.u.) is dominant rather than the expected oscillation frequency 
of 160 Hz. The second or higher harmonic frequencies could be generated from 
overlarge amplitude of particle displacement causing phase wrapping. In other words, 
the displacements of particles within the interval time of two successive samplings is 
too large, leading to the phase change of interferometric signal greDWHUWKDQʌ7KH
dominant magnetomotive signal (320 Hz) is extracted using a bandpass filter for 
forming image of MGQD labelled cells, shown in Figure 7c. The MGQD labelled 
cells are visualized successfully, which demonstrates the feasibility of using MGQD 
as a contrast agent for MMOCT. However, it is apparent that the magnetomotive 
signal of MGQD can also be detected inside agar gel. This phenomenon could be 
explained by the MGQD diffusing into the agar gel, by the MGQD on the agar surface 
forming a shadow DUWHIDFWEHQHDWKVXUIDFHVLPLODUWRWKH³VKRZHUFXUWDLQ´HIIHFWLQ
OCT angiography) or the MGQD inducing a bulk vibration of agar. In Figure 7 d, e 
and f, the same amount of unlabeled 3T3 cells on agar surface as the negative control 
are imaged in the same way. No magnetomotive signal is detected for the negative 
  
control, which confirms the magnetomotive signal resulting from oscillation of 
MGQD. 
 
MGQD has demonstrated effectiveness as an MMOCT tracer, and low concentrations 
of MGQD can be used to label cells whilst producing identifiable magnetomotive 
VLJQDO,QRXUH[SHULPHQWWKHPLQLPXPXVHDEOH0*4'FRQFHQWUDWLRQLVȝJP/
Quantitative analyses of MGQD uptake in cells using magnetomotive signal intensity 
is complicated, because the magnetomotive signal of MGQD is partially redistributed 
to its higher harmonics. The magnetomotive signal redistribution arises from phase 
wrapping, which could be prevented by using a higher line scan rate or lower 
magnetic field strength [54]. Therefore, MGQD has the potential for quantitative 
measurement of labelled cells. 
 
 
FIGURE 7. The MMOCT images of MGQD labelled 3T3 cells and unlabeled 3T3 cells on 
agar gel. a: the original B-VFDQ2&7LPDJHRIȝJP/0*4'ODEHOOHGFHOOVZLWKRXW
MMOCT signal processing, where the cell intensity imaged is approximately  ൈ
cell/cm2; b: the phase frequency spectrum of magnetomotive signal of MGQD labelled 
cells; c: the MGQD labelled cells phantom results from MMOCT signal processing of 320 Hz 
magnetomotive signal; d, e and f are the images and spectrum of unlabeled cells for negative 
control, which are original B-scan OCT image, phase frequency spectrum and MMOCT 
image respectively. 
a b c 
d e f 
  
 
4. CONCLUSION 
MGQD nanoparticles were synthesized by hydrothermal reduction of iron oxide 
coated graphene oxide sheets. The MGQD shows up as a small round thin sheet (15 
nm of average diameter) with low toxicity to cells, which allows MGQD to be easily 
internalized into cells for labeling. The iron oxides and graphene of MGQD can offer 
superparamagnetism and tunable blue fluorescence simultaneously. These properties 
suggest that MGQD can be used as a dual-modality contrast agent for CFM and 
MMOCT. The MGQD labeled cells have been successfully tracked and visualized by 
a commercial CFM and our in-house MMOCT system. Application of MGQD for cell 
tracking could provide anatomical information via MMOCT and intracellular details 
via CFM, thereby achieving a more comprehensive diagnosis. 
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